e-learning
resources
Munich 2006
Monday 04.09.2006
Continuous positive airflow pressure (CPAP) therapy
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
CPAP variability in long term follow-up of OSAS (obstructive sleep apnea syndrome) patients
L. Karasulu, A. Uysal, L. Dalar, S. Altin, P. Ozkan, C. Caglar (Istanbul, Turkey)
Source:
Annual Congress 2006 - Continuous positive airflow pressure (CPAP) therapy
Session:
Continuous positive airflow pressure (CPAP) therapy
Session type:
Thematic Poster Session
Number:
2419
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Karasulu, A. Uysal, L. Dalar, S. Altin, P. Ozkan, C. Caglar (Istanbul, Turkey). CPAP variability in long term follow-up of OSAS (obstructive sleep apnea syndrome) patients. Eur Respir J 2006; 28: Suppl. 50, 2419
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
PERIPHERAL ARTERIAL TONOMETRY AND INTIMA MEDIA THICKNESS IN OBSTRUCTIVE SLEEP APNEA.
Related content which might interest you:
PAI-uPA system in patients with obstructive sleep apnea syndrome (OSAS) in CPAP treatment
Source: Annual Congress 2012 - Cardiovascular disease and sleep-disordered breathing
Year: 2012
Compliance with nCPAP in elderly patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004
Effects of long term nCPAP treatment on patients with obstructive sleep apnoea syndrom
Source: Eur Respir J 2007; 30: Suppl. 51, 322s
Year: 2007
Pitolisant long term effect in sleepy obstructive sleep apnea patients without CPAP.
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021
Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP.
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021
Residual sleepiness in obstructive sleep apnea (OSA) patients on CPAP: Not only a symptom but rather a true syndrome?
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012
CPAP treatment for obstructive sleep apnoea syndrome after CPAP training term
Source: Eur Respir J 2002; 20: Suppl. 38, 102s
Year: 2002
Effects of CPAP treatment on physical fitness in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2003; 22: Suppl. 45, 97s
Year: 2003
Pitolisant long term effect in sleepy obstructive sleep apnea patients without CPAP
Source: Sleep and Breathing Conference 2021
Year: 2021
Pitolisant long term effect in sleepy obstructive sleep apnea patients with CPAP
Source: Sleep and Breathing Conference 2021
Year: 2021
Does personality change in obstructive sleep apnea (OSA) patients using CPAP?
Source: Eur Respir J 2006; 28: Suppl. 50, 409s
Year: 2006
Daytime hypoxemia in obstructive sleep apnoea (OSA) subjects before CPAP therapy
Source: Annual Congress 2009 - Clinical aspects of sleep apnoea
Year: 2009
Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006
The clinical significance nocturnal hypoventilation (NH) in patients with severe obstructive sleep apnoea (OSA)
Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification
Year: 2020
Secondary hypogonadism induced by severe obstructive sleep apnea syndrome (OSAS) and results after two months CPAP treatment
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
A comparison of laboratory polysomnography and a home sleep study in the diagnosis of obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Screening for sleep-disordered breathing
Year: 2010
The effect of theophylline and CPAP on cytokine release in patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2006; 28: Suppl. 50, 216s
Year: 2006
Evolution of treatment with CPAP over 21 months of follow-up in patients with sleep apnea hypopnea syndrome
Source: Annual Congress 2011 - Epidemiology, diagnosis and treatment in obstructive sleep apnoea
Year: 2011
CPAP induces structural changes in the inspiratory muscles of patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 222s
Year: 2002
Daytime hypercapnia in patients with obstructive sleep apnoea syndrome (OSAS)
Source: Eur Respir J 2002; 20: Suppl. 38, 493s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept